Skip to main content

Table 1 Characteristics and variables used to calculate APPROVE score in each cohort

From: Multicenter derivation and validation of an early warning score for acute respiratory failure or death in the hospital

 

Retrospective 2013 cohort

Prospective 2017 cohort

Variable

Fitting cohort

(N = 34,387)

Validation cohort

(N = 34,388)

Total

(N = 68,775)

Number (%) missing

Validation cohort

(N = 2258)

Number (%) missing

Qualifying event, yes

958 (3%)

1072 (3%)

2030 (3%)

0 (0%)

35 (1.5%)

0 (0%)

Demographics

 Age

57.8 ± 19.5

58.0 ± 19.5

57.9 ± 19.5

0 (0%)

55.9 ± 20.4

0 (0%)

 Body mass index

29.6 ± 9.0

29.6 ± 8.9

29.6 ± 9.0

12,595 (18%)

31.3 ± 9.2

146 (6.4%)

 Height (cm)

165.8 ± 12.8

165.6 ± 13.0

165.7 ± 12.9

11,900 (17%)

163.4 ± 10.4

136 (6.0%)

 Sex, female

20,452 (59%)

20,595 (60%)

41,047 (60%)

0 (0%)

1658 (67%)

0 (0%)

 Weight (kg)

81.6 ± 26.9

81.4 ± 26.9

81.5 ± 26.9

7907 (11%)

83.4 ± 27.7

99 (4.4%)

Medication use (yes)*

 Dobutamine

24 (0%)

22 (0%)

46 (0%)

0 (0%)

0

0 (0%)

 Dopamine

20 (0%)

20 (0%)

40 (0%)

0 (0%)

0

0 (0%)

 Epinephrine

6 (0%)

3 (0%)

9 (0%)

0 (0%)

0

0 (0%)

 Norepinephrine

165 (0%)

137 (0%)

302 (0%)

0 (0%)

4

0 (0%)

 Vasopressin

17 (0%)

13 (0%)

30 (0%)

0 (0%)

2

0 (0%)

 Oxygen requirement, FiO2

0.5 ± 0.2

0.5 ± 0.2

0.5 ± 0.2

0 (0%)

0.5 ± 0.3

0 (0%)

 RASS

−0.8 ± 1.5

−0.8 ± 1.5

−0.8 ± 1.5

59,105 (86%)

−0.89 (1.76)

2245 (99.3%)

Oxygen devices

   

0 (0%)

 

0 (0%)

 Room air (or no device)

30,677 (89%)

30,557 (89%)

61,234 (89%)

 

1684 (68%)

 

 Flow/hood/tent/isolette/mask

76 (0%)

81 (0%)

157 (0%)

 

8 (0%)

 

 Low-flow nasal cannula

3409 (10%)

3535 (10%)

6944 (10%)

 

650 (26%)

 

 High-flow nasal cannula

7 (0%)

6 (0%)

13 (0%)

 

17 (1%)

 

 Nonrebreather mask

66 (0%)

63 (0%)

129 (0%)

 

31 (1%)

 

 CPAP, AVAPS, or BIPAP

152 (0%)

146 (0%)

298 (0%)

 

70 (3%)

 

Vital signs

 Systolic blood pressure

125.9 ± 21.8

126.4 ± 21.8

126.2 ± 21.8

3575 (5%)

129.0 ± 13.6

3 (0%)

 Diastolic blood pressure

68.9 ± 14.3

68.9 ± 14.3

68.9 ± 14.3

3612 (5%)

69.9 ± 13.6

3 (0%)

 Heart rate

82.7 ± 16.8

82.1 ± 16.8

82.4 ± 16.8

5842 (8%)

83.3 ± 15.8

3 (0%)

 Respiratory rate

19.0 ± 3.6

18.9 ± 3.4

18.9 ± 3.5

3876 (6%)

18.79 ± 3.72

2 (0%)

 Oxygen saturation

97.8 ± 3.5

97.8 ± 3.5

97.8 ± 3.5

11,424 (17%)

96.9 ± 6.3

85 (4%)

 Temperature (C)

36.8 ± 0.6

36.8 ± 0.5

36.8 ± 0.5

3796 (6%)

36.9 ± 0.5

3 (0%)

Laboratory findings

 Arterial PaCO2 (mmHg)

39.9 ± 10.6

39.9 ± 10.4

39.9 ± 10.5

58,426 (85%)

45.3 ± 12.8

1819 (74%)

 Arterial PaO2 (mmHg)

134.0 ± 80.9

134.2 ± 81.2

134.1 ± 81.1

58,430 (85%)

80.9 ± 60.0

1862 (76%)

 Arterial pH

7.4 ± 0.1

7.4 ± 0.1

7.4 ± 0.1

58,422 (85%)

7.4 ± 0.1

1819 (74%)

 Hematocrit (%)

31.9 ± 6.4

32.0 ± 6.4

31.9 ± 6.4

4273 (6%)

32.6 ± 6.4

81 (3%)

 Hemoglobin (g/dl)

10.6 ± 2.2

10.6 ± 2.2

10.6 ± 2.2

4301 (6%)

10.9 ± 2.1

81 (3%)

 Platelet count (1000/μl)

227.7 ± 113.1

227.6 ± 113.9

227.7 ± 113.5

4306 (6%)

237.3 ± 101.9

85 (4%)

 White blood count (1000/μl)

10.0 ± 7.8

10.0 ± 7.8

10.0 ± 7.8

4305 (6%)

9.7 ± 4.8

85 (4%)

 Lactate (arterial or venous) (nM/L)

2.8 ± 3.2

2.1 ± 2.0

2.5 ± 2.8

67,076 (98%)

2.1 ± 1.3

1888 (77%)

 Serum albumin (g/dl)

3.4 ± 0.7

3.4 ± 0.7

3.4 ± 0.7

22,145 (32%)

3.5 ± 0.7

1187 (48.3%)

 Serum bicarbonate (meq/l)

23.8 ± 4.2

23.8 ± 4.2

23.8 ± 4.2

7058 (10%)

24.8 ± 4.2

254 (10%)

 Serum calcium (mg/dl)

8.8 ± 0.8

8.8 ± 0.8

8.8 ± 0.8

12,099 (18%)

8.8 ± 0.8

254 (10%)

 Serum chloride (meq/l)

102.1 ± 6.0

102.1 ± 6.0

102.1 ± 6.0

7055 (10%)

102.1 ± 5.7

254 (10%)

 Serum creatinine (mg/dl)

1.7 ± 1.9

1.7 ± 1.9

1.8 ± 1.9

6681 (10%)

1.6 ± 1.9

254 (10%)

 Serum glucose (mg/dl)

139.2 ± 73.8

139.0 ± 74.4

139.1 ± 74.1

6836 (10%)

145.0 ± 75.6

251 (10%)

 Serum potassium (meq/l)

4.1 ± 0.6

4.1 ± 0.6

4.1 ± 0.6

6883 (10%)

4.3 ± 0.6

251 (10%)

 Serum sodium (meq/l)

138.1 ± 5.0

138.1 ± 5.0

138.1 ± 5.0

6858 (10%)

140.5 ± 5.0

247 (10%)

 Serum total bilirubin (mg/dl)

1.6 ± 3.7

1.5 ± 3.5

1.5 ± 3.6

21,489 (31%)

1.4 ± 3.5

1192 (48%)

 Anion gap

15.9 ± 3.4

15.9 ± 3.4

15.9 ± 3.4

14,453 (21%)

18.08 ± 3.50

257 (11.3%)

  1. Data presented as counts and percentages or mean ± standard deviation
  2. APPROVE Accurate Prediction of Prolonged Ventilation, AVAPS average volume assured pressure support, BIPAP bilevel positive airway pressure, CPAP continuous positive airway pressure, FiO2 fraction of inspired oxygen, PaCO2 partial pressure of carbon dioxide, PaO2 partial pressure of oxygen, RASS Richmond Agitation-Sedation Scale
  3. *Any use of indicated medication at selected time point